CA2006189A1 - Derives tetrapeptidiques inhibiteurs de la cck - Google Patents

Derives tetrapeptidiques inhibiteurs de la cck

Info

Publication number
CA2006189A1
CA2006189A1 CA002006189A CA2006189A CA2006189A1 CA 2006189 A1 CA2006189 A1 CA 2006189A1 CA 002006189 A CA002006189 A CA 002006189A CA 2006189 A CA2006189 A CA 2006189A CA 2006189 A1 CA2006189 A1 CA 2006189A1
Authority
CA
Canada
Prior art keywords
asp
phe
lys
trp
epsilon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002006189A
Other languages
English (en)
Inventor
Alex M. Nadzan
Hana Kopecka
Youe-Kong Shue
Kazumi Shiosaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CA2006189A1 publication Critical patent/CA2006189A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002006189A 1988-12-21 1989-12-20 Derives tetrapeptidiques inhibiteurs de la cck Abandoned CA2006189A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28795588A 1988-12-21 1988-12-21
US287,955 1988-12-21

Publications (1)

Publication Number Publication Date
CA2006189A1 true CA2006189A1 (fr) 1990-06-21

Family

ID=23105106

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006189A Abandoned CA2006189A1 (fr) 1988-12-21 1989-12-20 Derives tetrapeptidiques inhibiteurs de la cck

Country Status (5)

Country Link
EP (1) EP0449884A4 (fr)
JP (1) JPH04502323A (fr)
CA (1) CA2006189A1 (fr)
GR (1) GR890100827A (fr)
WO (1) WO1990006937A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914334A1 (en) * 1990-12-17 1992-06-17 Black James Foundation Tetrapeptide derivatives and analogues
US5380872A (en) * 1992-07-14 1995-01-10 Glaxo Inc. Modulators of cholecystokinin
US5780464A (en) * 1994-10-14 1998-07-14 Glaxo Wellcome Inc. Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
GB9420748D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
FR2730998B1 (fr) * 1995-02-23 1997-04-04 Adir Nouveaux derives peptidiques agonistes de cholecystokinine
US6908900B2 (en) * 2001-01-17 2005-06-21 Zimmer & Associates Ag Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingredients
DE102006052755A1 (de) 2006-11-08 2008-05-15 N-Zyme Biotec Gmbh Michaelsysteme als Transglutaminaseinhibitoren

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986001720A1 (fr) * 1984-09-13 1986-03-27 Cytogen Corporation Conjugues d'agents therapeutiques-anticorps

Also Published As

Publication number Publication date
GR890100827A (el) 1991-03-15
JPH04502323A (ja) 1992-04-23
EP0449884A4 (en) 1991-10-30
EP0449884A1 (fr) 1991-10-09
WO1990006937A1 (fr) 1990-06-28

Similar Documents

Publication Publication Date Title
US5340802A (en) Peptide analog type-B CCK receptor ligands
CA1314655C (fr) Derives d'hydroxylamines
KR910002544B1 (ko) 노르-스타틴 및 노르-사이클로스타틴 폴리펩타이드
KR890003602B1 (ko) 옥사-및 아자호모사이클로스타틴 폴리펩티드의 제조방법
CA2020065A1 (fr) Ligand recepteur cck de type b tetrapeptidique
EP0336356A2 (fr) Dérivés du tryptophane antagonistes des CCK
US5162336A (en) Tetrahydro-pyrido-indoles as cholecystokinin and gastrin antagonists
US5270302A (en) Derivatives of tetrapeptides as CCK agonists
AU711104B2 (en) Compounds with growth hormone releasing properties
EP1392721A1 (fr) Peptides et utilisation de ceux-ci en tant qu'inhibiteurs de la protease ns3 du virus de l'hepatite c
JPH11500107A (ja) 成長ホルモン放出特性をもつ化合物
ES2331102T3 (es) Compuestos con propiedades de liberacion de la hormona del crecimiento.
EP0632052B1 (fr) Peptides ayant une activité antagoniste d'endothéline
US5817654A (en) N-substituted naphthofused lactams
JPS63258894A (ja) アミノ酸誘導体
NO312242B1 (no) Forbindelser med veksthormonfrigjörende egenskaper, farmasöytiske preparater som omfatter dissse, samt anvendelse avforbindelsene til fremstilling av medikamenter
JP2002505677A (ja) 成長ホルモン放出特性をもつ化合物
NZ226395A (en) Renin-inhibiting amino acid derivatives and pharmaceutical compositions
CA2006189A1 (fr) Derives tetrapeptidiques inhibiteurs de la cck
US5128346A (en) Derivatives of D-glutamic acid and D-aspartic acid
HUT77979A (hu) Peptidek, előállításuk és ezeket tartalmazó gyógyszerkészítmények
RO115520B1 (ro) Derivati peptidici azacicloalchilalcanoil si intermediari pentru obtinerea acestora
WO1993018058A1 (fr) Imitateurs peptidiques utiles comme inhibiteurs de l'agregation plaquettaire
EP0361977A2 (fr) Peptides à activité T-cellules suppressives
HU187090B (en) Process for producing substituted dipeptides

Legal Events

Date Code Title Description
FZDE Dead